Literature DB >> 32037821

Understanding Idiosyncratic Toxicity: Lessons Learned from Drug-Induced Liver Injury.

Merrie Mosedale1, Paul B Watkins1.   

Abstract

Idiosyncratic adverse drug reactions (IADRs) encompass a diverse group of toxicities that can vary by drug and patient. The complex and unpredictable nature of IADRs combined with the fact that they are rare makes them particularly difficult to predict, diagnose, and treat. Common clinical characteristics, the identification of human leukocyte antigen risk alleles, and drug-induced proliferation of lymphocytes isolated from patients support a role for the adaptive immune system in the pathogenesis of IADRs. Significant evidence also suggests a requirement for direct, drug-induced stress, neoantigen formation, and stimulation of an innate response, which can be influenced by properties intrinsic to both the drug and the patient. This Perspective will provide an overview of the clinical profile, mechanisms, and risk factors underlying IADRs as well as new approaches to study these reactions, focusing on idiosyncratic drug-induced liver injury.

Entities:  

Year:  2020        PMID: 32037821     DOI: 10.1021/acs.jmedchem.9b01297

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  8 in total

1.  Diminishing GSH-Adduct Formation of Tricyclic Diazepine-based Mutant IDH1 Inhibitors.

Authors:  Chunhui Huang; Christian Fischer; Michelle R Machacek; Stephane Bogen; Tesfaye Biftu; Xianhai Huang; Michael H Reutershan; Ryan Otte; Qingmei Hong; Zhicai Wu; Yang Yu; Min Park; Lei Chen; Purakkattle Biju; Ian Knemeyer; Ping Lu; Christopher J Kochansky; Michael Brendan Hicks; Yong Liu; Roy Helmy; Xavier Fradera; Anthony Donofrio; Josh Close; Matthew L Maddess; Catherine White; David L Sloman; Nunzio Sciammetta; Jun Lu; Craig Gibeau; Vladimir Simov; Hongjun Zhang; Peter Fuller; David Witter
Journal:  ACS Med Chem Lett       Date:  2022-03-28       Impact factor: 4.345

2.  Human-relevant mechanisms and risk factors for TAK-875-Induced liver injury identified via a gene pathway-based approach in Collaborative Cross mice.

Authors:  Merrie Mosedale; Yanwei Cai; J Scott Eaddy; Patrick J Kirby; Francis S Wolenski; Yvonne Dragan; William Valdar
Journal:  Toxicology       Date:  2021-08-18       Impact factor: 4.571

3.  A novel pipeline of 2-(benzenesulfonamide)-N-(4-hydroxyphenyl) acetamide analgesics that lack hepatotoxicity and retain antipyresis.

Authors:  Hernan A Bazan; Surjyadipta Bhattacharjee; Carolina Burgos; Javier Recio; Valentina Abet; Amanda R Pahng; Bokkyoo Jun; Jessica Heap; Alexander J Ledet; William C Gordon; Scott Edwards; Dennis Paul; Julio Alvarez-Builla; Nicolas G Bazan
Journal:  Eur J Med Chem       Date:  2020-06-30       Impact factor: 6.514

4.  Modifications of the Triaminoaryl Metabophore of Flupirtine and Retigabine Aimed at Avoiding Quinone Diimine Formation.

Authors:  Konrad W Wurm; Frieda-Marie Bartz; Lukas Schulig; Anja Bodtke; Patrick J Bednarski; Andreas Link
Journal:  ACS Omega       Date:  2022-02-25

5.  An Engineered Protein-Based Building Block (Albumin Methacryloyl) for Fabrication of a 3D In Vitro Cryogel Model.

Authors:  Xueming Niu; Mian Lin; Bae Hoon Lee
Journal:  Gels       Date:  2022-06-25

6.  Machine Learning for Predicting Risk of Drug-Induced Autoimmune Diseases by Structural Alerts and Daily Dose.

Authors:  Yue Wu; Jieqiang Zhu; Peter Fu; Weida Tong; Huixiao Hong; Minjun Chen
Journal:  Int J Environ Res Public Health       Date:  2021-07-03       Impact factor: 3.390

Review 7.  Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice.

Authors:  Marina Villanueva-Paz; Laura Morán; Nuria López-Alcántara; Cristiana Freixo; Raúl J Andrade; M Isabel Lucena; Francisco Javier Cubero
Journal:  Antioxidants (Basel)       Date:  2021-03-05

8.  Regulation of the immune tolerance system determines the susceptibility to HLA-mediated abacavir-induced skin toxicity.

Authors:  Takeshi Susukida; Saki Kuwahara; Binbin Song; Akira Kazaoka; Shigeki Aoki; Kousei Ito
Journal:  Commun Biol       Date:  2021-09-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.